Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AMP-224 |
Synonyms | |
Therapy Description |
AMP-224 is a fusion protein comprised of the extracellular domain of PD-L2 (PDCD1LG2) and the Fc region of IgG1, which binds to the PD-1 (PDCD1) receptor thereby potentially resulting in restoration of the T-cell mediated immune response (PMID: 31351862). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMP-224 | AMP224|AMP 224 | Immune Checkpoint Inhibitor 147 PD-L1/PD-1 antibody 117 | AMP-224 is a fusion protein comprised of the extracellular domain of PD-L2 (PDCD1LG2) and the Fc region of IgG1, which binds to the PD-1 (PDCD1) receptor thereby potentially resulting in restoration of the T-cell mediated immune response (PMID: 31351862). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|